Company overview
Integrated DNA Technologies (IDT) is the world's largest manufacturer of custom nucleic acids, including oligonucleotides, genes, and gene fragments essential for genomics research in pharmaceuticals and biotechnology. They offer synthetic biology solutions like rapid genes (NGS-verified, shipped in 5 days), Ultramer DNA oligos up to 200 bases, and complex clonal DNA up to 50 kb via partnerships, supporting applications in next-generation sequencing, CRISPR editing, cell/gene therapy, and vaccine research. With manufacturing sites across the USA, Belgium, and Singapore, IDT serves over 90,000 customers globally, including pharma, with advanced synthesis, modification, and quality control capabilities.
Products and technologies associated with IDT include Synthesis — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.idtdna.com/page
- Markets served
- United States & Americas
- Keywords
- idt custom oligos, nucleic acid synthesis, synthetic biology genes, ngs verified dna, pharma genomics supplier
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What custom nucleic acid products does IDT offer for pharma R&D?
- IDT provides custom oligonucleotides (up to 200 bases via Ultramer), rapid genes (125-2000 bp, NGS-verified, shipped in 5 days), gene fragments, vectors, and clonal DNA/XL DNA (100 bp-50 kb) for synthetic biology, NGS, CRISPR, and gene therapy applications.
- What are IDT's manufacturing capabilities and quality standards?
- IDT features advanced oligonucleotide synthesis, modification, purification, and QC with over 35 years of expertise; products like rapid genes are NGS-verified, and they offer plate formats for high-throughput workflows.
- Where does IDT manufacture and serve customers geographically?
- Manufacturing headquarters in Coralville, Iowa, USA, with additional sites in San Diego CA, Boulder CO, Research Triangle Park NC, Ann Arbor MI (USA), Leuven (Belgium), and Singapore; serves 90,000+ customers globally including pharma.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
